Pakistan authorized the use of the AstraZeneca COVID-19 vaccine recently. Approved for emergency use, the vaccine originally developed at University of […]
The AstraZeneca COVID-19 vaccine trial, investigating the safety and efficacy of the “Oxford” vaccine now known as AZD1222, has come […]
Recently, experts from Oxford University and the World Health Organization (WHO) shared that additional data would be required about AZD1222, […]
The world has placed high hopes on the COVID-19 vaccine candidate originally developed in Oxford (ChAdOx1 nCoV-19) and now licensed […]
What does a niche vaccine-focused biotech from Gaithersburg, MD toiling in relative obscurity for years and a small Native American […]
The University of Vermont Medical Center was selected as a trial site location by AstraZeneca for the Phase COVID-19 clinical […]
Although TrialSite reported yesterday that both the AstraZeneca and the Johnson & Johnson vaccine trials received the U.S. Food and Drug […]
Shares of AstraZeneca’s stock declined as a volunteer participating in the Phase 3 clinical trial in Brazil died, reports Brazil’s […]
The nation of Indonesia, the fourth most populous worldwide, has inked a deal with AstraZeneca to buy 100 million COVID-19 […]
The European Medicines Agency (EMA) human medicines committee (CHMP) reports publicly the first ‘rolling review’ of a COVID-19 vaccine starting […]
